title: Long-term survival in patients with Ewing's sarcoma relapsing after completing therapy.
abstract: While the proportion of patients with Ewing's sarcoma attaining and maintaining long-term remission has markedly improved, a proportion of patients suffer relapse of the tumor. In our experience relapses may occur late in the course of the disease, approximately 20% of those at risk beyond 5 years having recurrence of tumor. Review of our data indicates that for patients relapsing after therapy has been discontinued, the probability of attaining second remission is high (0.84) and that a significant proportion of these patients attaining second complete remission will survive their disease (0.60).
authors: Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, TN 38101.
authors: F A
authors: FA
authors: Hayes
authors: E I
authors: EI
authors: Thompson
authors: M
authors: M
authors: Kumar
authors: H O
authors: HO
authors: Hustu
mesh_terms: D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D011379:Prognosis; D012074:Remission Induction; D012512:Sarcoma, Ewing / Q000473:pathology / Q000628:therapy*